Published in Mol Imaging Biol on December 21, 2007
Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med (2014) 1.94
A Systematic Approach for Developing Bacteria-Specific Imaging Tracers. J Nucl Med (2016) 0.83
Re: Increased 18F-2-Fluorodeoxysorbitol (18F-FDS) Activity in a Pituitary Spindle Cell Carcinoma. Clin Nucl Med (2017) 0.75
A tabulated summary of the FDG PET literature. J Nucl Med (2001) 4.37
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res (2004) 3.13
Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med (1996) 1.95
A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression. J Nucl Med (2006) 1.83
Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med (1998) 1.54
Fast and robust registration of PET and MR images of human brain. Neuroimage (2004) 1.41
Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med (2003) 1.37
18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med (2006) 1.37
Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging (2002) 1.33
Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res (2002) 1.30
Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism. Proc Natl Acad Sci U S A (1983) 1.29
In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model. Mol Imaging Biol (2006) 1.26
Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology. Mol Imaging Biol (2006) 1.25
X-ray crystallographic and kinetic studies of human sorbitol dehydrogenase. Structure (2003) 1.08
Synthesis and properties of 18F-labeled potential myocardial blood flow tracers. Nucl Med Biol (2001) 1.08
The use of fluoro- and deoxy-substrate analogs to examine binding specificity and catalysis in the enzymes of the sorbitol pathway. Carbohydr Res (1998) 1.06
The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation. Nucl Med Biol (2001) 1.01
Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability. Echocardiography (2005) 0.99
PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiol Clin North Am (2005) 0.99
FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med (2000) 0.88
Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model. J Nucl Med (1996) 0.81
[PET and malignant cerebral tumors]. Presse Med (2006) 0.79